{"id":"NCT02388724","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis","officialTitle":"A Randomized, Double-Blind, Double-Dummy Phase 3 Study to Evaluate the Efficacy and Safety of Oral Once-Daily Administration of TAK-438 20 mg Compared to Lansoprazole 30 mg in the Treatment of Subjects With Erosive Esophagitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03-24","primaryCompletion":"2017-07-27","completion":"2017-07-27","firstPosted":"2015-03-17","resultsPosted":"2019-06-03","lastUpdate":"2019-06-03"},"enrollment":481,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Erosive Esophagitis"],"interventions":[{"type":"DRUG","name":"Vonoprazan","otherNames":["TAK-438"]},{"type":"DRUG","name":"Lansoprazole","otherNames":["Prevacid"]},{"type":"DRUG","name":"Vonoprazan Placebo","otherNames":[]},{"type":"DRUG","name":"Lansoprazole Placebo","otherNames":[]}],"arms":[{"label":"Vonoprazan 20 mg","type":"EXPERIMENTAL"},{"label":"Lansoprazole 30 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to demonstrate the efficacy of vonoprazan (TAK-438) versus lansoprazole in the treatment of erosive esophagitis classified as Los Angeles (LA) classification grades A to D at Week 8.","primaryOutcome":{"measure":"Percentage of Participants With Endoscopic Healing of Erosive Esophagitis During the 8-Week Treatment Phase","timeFrame":"8 weeks","effectByArm":[{"arm":"Vonoprazan 20 mg","deltaMin":92.4,"sd":null},{"arm":"Lansoprazole 30 mg","deltaMin":91.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":64,"countries":["China","Malaysia","South Korea","Taiwan"]},"refs":{"pmids":["31409606"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":244},"commonTop":["Blood gastrin increased"]}}